GLP-1s in Hip and Knee Arthroplasty

NCT07755085 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Arthritis
Obesity & Overweight
GLP - 1

Interventions

DRUG: GLP-1 Receptor Agonists + Behavioral modification
BEHAVIORAL: Behavioral + placebo

Sponsor

Nova Scotia Health Authority

Collaborators

[object Object]
[object Object]
[object Object]